News

Long-acting opioids increase cardiovascular deaths in noncancer patients


 

FROM JAMA

References

Long-acting opioids increased the risk of all-cause mortality in patients with chronic noncancer pain, based on 22,912 new episodes of long-acting opioid prescription and an equal number of control prescriptions during an average follow-up of 176 days and 128 days respectively.

In the follow-up period, 185 people given long-acting opioids and 87 in the control group died. The hazard ratio for total mortality in the opioid group was 1.64, according to Wayne Ray, Ph.D., of Vanderbilt University, Nashville, and his associates.

Out-of-hospital deaths accounted for 154 deaths in the opioid group and 60 in the control group, with a hazard ratio of 1.9. The hazard ratio in the opioid group for out-of-hospital deaths other than unintentional overdose was 1.72. Cardiovascular events were the most common cause of death, accounting for 79 deaths in the opioid group and for 53 deaths in the control group. The hazard ratio for cardiovascular death was 1.65.

“The study finding that prescription of long-acting opioids was associated with increased cardiovascular and other nonoverdose mortality adds to the already considerable known harms of the opioids and thus should be considered when assessing the benefits and harms of medications for chronic pain,” the investigators noted.

Find the full study in JAMA (doi: 10.1001/jama.2016.7789).

lfranki@frontlinemedcom.com

Recommended Reading

Sweeping mental health reforms head for Senate floor
MDedge Psychiatry
Drug interaction myths
MDedge Psychiatry
Mindfulness, cognitive therapy top conventional care for low back pain
MDedge Psychiatry
FDA requires boxed warnings for short-acting opioids
MDedge Psychiatry
Anti-CGRP agent delivered durable episodic migraine prevention
MDedge Psychiatry
VIDEO: How to personalize pain management in era of opioids
MDedge Psychiatry
FDA panels recommend expanding REMS, requiring prescriber education, for ER/LA opioids
MDedge Psychiatry
Mindfulness on par with drugs for chronic migraine in patients who’ve overused medication
MDedge Psychiatry
Probuphine implant predicted to ease buprenorphine maintenance
MDedge Psychiatry
New fibromyalgia recommendations have firmer evidence base
MDedge Psychiatry